Obesity is a state of low-grade chronic systemic inflammation that induces a reduction of adiponectin production with inhibition of the vasorelaxant properties of perivascular adipose tissue with underlying widespread endothelial dysfunction. This review concentrates on the main pulmonary and non-pulmonary determinants of gas exchange abnormalities, characterized by mild-to-moderate increased alveolar-arterial O 2 difference, with or without mild hypoxaemia, in non-smoking morbidly obese subjects without associated relevant co-morbidities, candidates to bariatric surgery, induced by ventilation-perfusion imbalance and increased intrapulmonary shunt, including the effects of 100% oxygen breathing and those induced by postural changes. Likewise, we review lung imaging abnormalities, more specifically lung tissue volume, and their interaction with gas exchange disturbances. Finally, we address the long-term beneficial effects of bariatric surgery on all these obesity-induced lung function and imaging defects. Overall, we present a compelling evidence of lung function and imaging abnormalities underlying systemic and pulmonary inflammation in morbidly obese candidates to bariatric surgery. (BRN Rev. 2018;4:53-66)
INTRODUCTION
Obesity is defined as an abnormal or excessive fat accumulation and body mass index (BMI) is the most useful outcome to classify overweight and obesity in human beings. However, Vague [1] [2] [3] was the first to describe, in 1947, that the greater the excess of abdominal fat (visceral intra-abdominal fat) the greater the risk factor for obesity-related disease. Thus, measurements of central obesity, waist circumference (WC) and waist-tohip ratio (WHR), are considered to be good descriptors of obesity and correlate with intra-abdominal and subcutaneous adipose tissue while providing a simple and practical method to identify obese subjects at highest risk 2, 4, 5 .
The worldwide rising prevalence of overweight and obesity has been described as a global pandemic 4 because, during the last 35 years, the number of overweight and obese individuals increased from 857 million to 1.9 billion, currently representing a global prevalence of 39% 6, 7 . Moreover, the main burden of obesity lies on its interconnection with a number of metabolic and non-metabolic diseases including non-insulin-dependent diabetes mellitus, dyslipidaemia, arterial hypertension and atherosclerosis, leading by and large to a substantial increase in cardiovascular and cerebrovascular morbidity and mortality [6] [7] [8] [9] [10] . Given the rapid rise in obesity worldwide in recent years and the deleterious effects of both overweight and obesity in health and life expectancy, a thorough understanding of the physiological pathways of obesity relationships with or without multi-morbidities, including lung function abnormalities, becomes crucially important.
Alternatively, there are currently no truly effective pharmacological approaches to manage and treat obesity, especially in the morbidly obese individual. Moreover, diet therapy, with and without the support of health-care organizations, is relatively ineffective in treating severe obesity at the long-term. In 1991, the United States (US) National Institutes of Health established the indications of bariatric surgery in morbid obesity, namely BMI ≥ 40 or BMI ≥ 35 kg/m 2 in the presence of significant multi-morbidities 11 . It is of note, however, that bariatric surgery is the best currently available non-pharmacological treatment to achieve a sustained and significantly successful weight loss in severe obese subjects in whom the efforts of a medical therapy have failed [12] [13] [14] [15] . More importantly, these beneficial effects are associated with a very low incidence of morbidity and mortality [16] [17] .
MECHANICAL COMPRESSION OF ADIPOSE TISSUE ON LUNG FUNCTION
Obesity has a direct impact on respiratory well-being. The most consistently reported effect of obesity on lung function is a reduction in the functional residual capacity (FRC) and expiratory reserve volume (ERV) [18] [19] [20] [21] . Adipose tissue around the rib cage and abdomen and in the visceral cavity induces both thoracic external compression and cephalic migration of the diaphragm, hence reducing chest volume. Accordingly, there is an exponential relationship between BMI increases (even with modest weight gain) and decreases in FRC and ERV 18 . However, the effects of obesity on the extremes of lung volumes, i.e. total lung capacity (TLC) and residual volume (RV), and on forced spirometry, such as forced expiratory volume in 1 s (FEV 1 ) and forced vital capacity (FVC), are modest with values slightly reduced or maintained within the normal limits [18] [19] [20] . It is of note that the regional distribution of fat, in particular in central obesity, has an important effect on lung function. Thus, the higher the central obesity measured by both a larger WC and WHR, the more marked the ERV reduction 22 .
As expected, severe obesity is also associated with impaired pulmonary gas exchange (Table 1) [22] [23] [24] [25] [26] [27] [28] [29] , which may increase the risk of post-operative pulmonary complications and have a deleterious effect on obesity-related multi-morbidities. Mild arterial hypoxaemia 30, 31 .
The compelling evidence of lung volume reduction, mainly located in the lower parts of the lung with collapse of the underlying parenchyma provoke atelectasis with absence of alveolar gas, was based on two important studies. Holley et al. 32 were the first to report regional distributions of ventilation-perfusion relationships using a radioactive xenon technique in severe obese subjects (BMI, 39 ± [SD] 4 kg/m 2 ) when upright. In this study, the distribution of perfusion was predominantly diverted to the lower lung zones, but in half of the subjects, with a lower ERV (ERV < 0.4 L; 21% predicted), distribution of ventilation was reversed, being the upper lung regions relatively better ventilated than the lower ones, while the dependent zones were under-ventilated inducing the development of airway collapse and atelectasis. Similarly, two years later, Barrera et al. 33 reported in severe obese subjects the presence of shunt using the mixed venous admixture ratio measurement, suggesting that arterial hypoxaemia was related to over-perfusion of under-ventilated areas and/or to perfusion of completely non-ventilated areas (i.e. intrapulmonary shunt). Moreover, due to the increased presence of airway closure in dependent lung regions, obesity further reduces FRC 20, 34 . Airway closure is a physiological phenomenon that occurs during expiration, with or without re-opening of airways during the succeeding inspiration 35 . During ambient air tidal breathing, it is more likely that airways will close in older normal weight subjects (65-70 years) when upright 36, 37 . Moreover, the reduction of FRC promotes airway closure in dependent lung regions and this reduction is more marked in Trendelenburg and headdown positions, in which there is a cranial displacement of the diaphragm. Farebrother et al. 23 observed, in a small subset of 8 severe obese individuals (4 men; BMI, 42 kg/m 2 ; 7 current smokers), a reduction in ERV below closing volume and a positive relationship between ERV and arterial PO 2 (Table 1) . Likewise, they demonstrated a close correlation between arterial PO 2 and the extent of airway closure within the range of tidal breathing, as a mechanism of basal lung hypoventilation, already previously acknowledged by Holley et al. 32 .
More recently, the pulmonary and non-pulmonary factors of gas exchange were comprehensively investigated using the inert gas technique 38 . This approach, considered to be one of the most robust tools for the assessment of pulmonary gas exchange, facilitated the thorough unravelling of all pulmonary gas exchange determinants in non-smoking morbidly obese women, with or without moderate-to-severe sleep apnoea, most likely to be extended to males. It was observed that despite a minor reduction of lung volumes, these individuals had pulmonary gas exchange abnormalities characterized by widened alveolar-arterial O 2 difference (27 ± 2 mmHg) and mild arterial hypoxaemia (76 ± 2 mmHg), due to mild-to-moderate increased intrapulmonary shunt (i.e. non-ventilated alveolar units) associated with increased dispersion of pulmonary blood flow and of alveolar ventilation distributions 30 ; by contrast, diffusion limitation to oxygen was completely absent. It is of note that the non-pulmonary determinants of pulmonary gas exchange, namely cardiac output, overall ventilation and oxygen consumption, were within normal limits 30, 31 . It is also of interest to draw the attention to the finding that, overall, the presence of gas exchange disturbances in the morbidly obese was almost identical to that shown in patients with extensive pleural effusion (liquid volume range, 0.5-1.0 L) that mechanically compresses the underlying lung parenchyma. Figure 1 illustrates for comparison the . Principal pulmonary gas exchange indices from two studies in patients with pleural effusion (red bars) 39 and in obese subjects (blue bars) 30 . In pleural effusion, although arterial PO 2 was within normal limits, alveolar-arterial O 2 difference was slightly increased and ventilation-perfusion distributions were broadened, as reflected by an increased blood flow distribution, along with mild intrapulmonary shunt. Note the similarities in all indices between the two clinical conditions, suggesting a similar mechanism, i.e. compression of the lung parenchyma by massive pleural fluid or extra-pulmonary massive adipose tissue. Arterial PO 2 and alveolar-arterial O 2 difference values are expressed in mmHg, dispersion of pulmonary blood flow is dimensionless, and intrapulmonary shunt in percentage of cardiac output. Shaded areas represent normal limits for each variable (shunt value is almost negligible [< 1% of cardiac output]). pulmonary gas exchange indices of patients with pleural effusion, showing values quite close to those of obese individuals. Although mean arterial PO 2 was within normal limits in the latter patients, alveolar-arterial O 2 difference was abnormally increased due to an increased dispersion of pulmonary blood flow distribution (which reflects areas with low ventilation-perfusion ratios), with mild increased intrapulmonary shunt 39 . The contention was that pleural effusion induces regions with low ventilation-perfusion ratios mostly related to the degree of lung collapse caused by the accumulation of fluid in the pleural cavity. Accordingly, we may extrapolate the latter contention to the status of obesity-induced gas exchange disturbances. These findings therefore suggest that the very abundant abdominal adipose tissue that characterizes very severe obesity may result in an excessive and unopposed intra-abdominal pressure that mechanically compresses the lower regions of the lungs and provokes areas of low ventilation-perfusion ratios with a mild amount of intrapulmonary shunt. Although the latter conclusion can be compelling, this should not be viewed as prove of this similarity being real as it is based on indirect comparison of data from two different studies 18 years apart.
CHRONIC SYSTEMIC INFLAMMATION AND PERIVASCULAR ADIPOSE TISSUE
It is well established that obesity is a state of low-grade chronic systemic inflammation [40] [41] [42] [43] . In the 1990s, the classical view of adipose tissue as an inert reservoir of energy storage was abandoned because it was demonstrated that: (1) there was a clear link between inflammation, obesity and insulin resistance [40] [41] [42] [43] [44] ; and, (2) adipose tissue was able to produce adipo-cytokines (adipocyte-derived hormones structurally similar to cytokines), such as leptin and adiponectin. Along these lines, it is of interest to highlight that Arismendi et al. 41 were able to provide an integrated network analysis of the interplay among the different serum inflammatory markers to characterize the features of inflammome as a network layout of the inflammatory pattern in the morbidly severe obese (Fig. 2) . Moreover, it has been suggested that the changes seen in adipose tissue in obesity are likely to have detrimental effects on vasoactive properties of perivascular adipose tissue 45 . Thus, the aberrant secretion of vasoactive molecules from adipose tissues is described as a key link between obesity and endothelial dysfunction, which is characterized by impaired vasodilatation and augmented vasoconstriction 43 . It has been demonstrated that in healthy individuals perivascular adipose tissue has anti-contractile effects 45 because adipocytes release adiponectin, which maintains endothelial nitrous oxide (NO) production, hence reducing vascular tone in human subcutaneous small arteries. In severe obesity, however, the anti-contractile capacity of perivascular adipose tissue is lost, because individual adipocyte size is greater and, consequently, there is local tissue hypoxia and inflammation. This milieu provides the stimulus for adipocyte and macrophage release of inflammatory cytokines. Both hypoxia and inflammation are known to reduce adiponectin production from adipocytes, so it was demonstrated that these stimuli inhibit the vasorelaxant properties of perivascular adipose tissue through increased oxidative stress. It is important to note that the increased serum biomarkers usually observed in morbidly obese individuals are not related to the indices of pulmonary gas exchange disturbances 30 .
OXYGEN-INDUCED PULMONARY GAS EXCHANGE ABNORMALITIES
In severe obese subjects 100% oxygen breathing induces a two-fold increase in intrapulmonary shunt without changes in the dispersion of the pulmonary blood flow distribution 30 . However, the bigger the intrapulmonary shunt induced by oxygen breathing, the greater the fall in the dispersion of pulmonary blood flow, a significant association that indicates an abnormal redistribution of pulmonary blood flow (Fig. 3A) , with associated systemic haemodynamic changes (increases in the systemic vascular resistance and arterial pressure due to a reduced cardiac output following a decrease in oxygen consumption). Most importantly, the oxygen-induced increment of intrapulmonary Figure 2 . Systemic inflammome characterized as a network analysis of the inflammatory pattern in healthy (left) participants and in obese candidates to bariatric surgery (right). Each node represents one inflammatory marker and each colour indicates the type of inflammatory marker considered (acute phase reactants, cytokines, adipokines or oxidative stress). The node diameter is proportional to the prevalence of abnormal values (i.e. 95th or 5th of controls) of that particular biomarker in the population under consideration (control or obese individuals) and the thickness of the edges linking pairs of nodes is proportional to the prevalence of co-occurrence of abnormal biomarkers of that particular pair of nodes. As expected, compared to control, obese individuals exhibited significantly higher mean concentrations of most serum inflammatory biomarkers except for adiponectin, which was lower (adapted with permission from Arismendi E et al. 41 ). CRP: C-reactive protein; IL: interleukin; sTNF-R1: soluble tumour necrosis factor-receptor 1. shunt observed, likely related to the development of lung areas with reabsorption atelectasis resulting from alveolar denitrogenation 46,47 , was not associated with reversion of hypoxic pulmonary vasoconstriction (as reflected by a lack of change in the dispersion of pulmonary blood flow distribution). Under conditions of hyperoxia, it has been consistently shown that low inspired ventilation-perfusion ratios, named "critical", become unstable and may ultimately collapse, thereby resulting in the development of reabsorption atelectasis 48 . Similarly, the simultaneous increases in mixed venous PO 2 also observed in morbid obese individuals during oxygen breathing facilitate the reduction of the pulmonary vascular tone 49 . Overall these findings may well reflect the presence of more rigid and fixed pulmonary vessels due to increased systemic (and perhaps pulmonary) inflammation in the context of an altered perivascular adipose tissue-induced endothelial dysfunction, already demonstrated in the cutaneous circulation 50 . This gas exchange pattern replicates what is usually observed in acute lung injury and acute respiratory distress syndrome (ARDS). Santos et al. 47 already demonstrated the effects of 100% oxygen breathing on pulmonary gas exchange indices in two subsets of patients, those with acute lung conditions and those with chronic obstructive airway diseases. Like in individuals with extreme obesity, patients with acute respiratory state diseases always significantly increase intrapulmonary shunt during hyperoxic conditions, while the redistribution of pulmonary blood flow remains unaltered; by contrast, those affected by chronic obstructive airway disease (i.e., COPD) always increase the blood flow dispersion distribution, without accompanying changes in the intrapulmonary shunt component, usually discrete under basal conditions, as shown in numerous gas exchange studies 49 . In obese subjects there is an accumulation of adipose tissue in the vascular walls of the systemic circulation, and even perhaps in the pulmonary vascular bed. All in all, these findings point to an abnormal pulmonary vascular likelihood in morbidly obese subjects underlying the abnormal gas exchange pattern of hyperoxic response 50 .
A model including the lungs, bone marrow, and adipose tissue as major components of a vascular interconnected network, that channels biological signals and facilitates their interaction, has been postulated for COPD 51 . Consequently, it has been suggested that the lung parenchyma and the systemic endothelium could act as the main external and internal sensors of the system, respectively, whereas the bone marrow and the adipose tissue are two important responding elements. According to this hypothesis, the development of COPD and associated multi-morbidities including obesity, may depend on the manner in which the interacting network responds, adapts, or fails to adapt (as modulated by the genetic and epigenetic background of the individual) to the initial pulmonary injury originally induced by inhaling those toxic gases and particles. This hypothetical model might well represent, at least in part, a complementary biologic mechanism to explain the altered perivascular adipose tissue shown in severe obesity.
POSTURAL-INDUCED GAS EXCHANGE ABNORMALITIES (ORTHODEOXIA)
Most tellingly, orthodeoxia (upright-induced arterial deoxygenation from recumbency) can be present in morbid obese individuals with arterial hypoxaemia at rest 31 , just as shown in other well-known conditions, such as opening of foramen ovale 52 and hepatopulmonary syndrome 53 . In the latter condition, the basic mechanism is due to further ventilation-perfusion worsening that reflects the development of more areas with low ventilation-perfusion ratios combined with some degree of increased intrapulmonary shunt. Presumably, this hepatic pattern of orthodeoxia reflects a more altered pulmonary vascular tone, more rigid and fixed, heterogeneously distributed so less liable to proportionately accommodate gravitational pulmonary blood flow changes to alveolar ventilation in dependent alveolar units. By contrast, in hypoxaemic morbidly obese subjects, oxygenation worsens when upright, as discretely as in liver diseases, because cardiac output decreases due to a simultaneous reduced venous return, without further ventilation-perfusion worsening 31 . Importantly, the critical difference in the obese pulmonary vasculature response is plausibly related to the distinct effects of 100% oxygen breathing. In severe obesity, hypoxic pulmonary vasoconstriction is not reversed during hyperoxic breathing, at variance with the usual release of hypoxic pulmonary vasoconstriction observed in chronic respiratory or liver disease states 49, 54 . As alluded to above, this is likely due to the presence of increased perivascular adipose tissue, with changes in extra-vascular lung water (see below), related to the underlying low-grade chronic systemic and lung inflammation 41, 55 . Should increases in cardiac output in the morbidly obese individuals be accompanied by higher increases in intrapulmonary shunt when supine, the net effect would have ultimately offset the observed improvement in arterial oxygenation.
LUNG IMAGING FINDINGS
High resolution thoracic computerized tomography (CT) scanning is currently considered one of the highest gold standards for evaluation of pulmonary structure and lung volumes 56 . In 1995, the definition of atelectasis as non-aerated lung volume (NALV) with a threshold density in CT scan between -100 to +100 Hounsfield units (HU) was established. This density analysis allows the quantification of atelectasis in relation to the total lung area. Using this density analysis, several studies have shown that impaired gas exchange in morbidly obese individuals during general anaesthesia is related to a higher development of atelectasis than in lean subjects [57] [58] [59] [60] . More recently, a new approach of non-contrast thoracic CT imaging to quantify changes in pulmonary vascular volume has been reported together with CT assessment of total lung tissue volume (Vtiss) defined as the volume of the lung not occupied by air. If large airways and vessels are excluded from the overall measurement as part of its definition, Vtiss therefore represents the volume occupied by parenchymal tissue and by pulmonary small vessels and capillaries 61, 62 . Thus, changes in Vtiss reflect all fluid changes within the lung including blood and interstitial fluids. Accordingly, an increase in Vtiss could also be caused by increases in pulmonary capillary blood volume and in the segmented vascular volume and/or by an increase of fluid in the parenchyma interstitial space. Using non-contrast CT 63 , it was possible to demonstrate an association between the cross-sectional area of pulmonary vessels with lung function 64 or pulmonary haemodynamics in selected cohorts of patients 65 .
Santos et al. 55 used this imaging approach to assess lung volumes in morbidly obese subjects and found that the densitometry analysis showed that hypo-aerated lung volume (-500 to -100 HU) was higher in obese individuals before bariatric surgery compared to normal-weighted subjects without differences at the end-expiratory lung volume and non-aerated lung volume (-100 to +100 HU) (Fig. 4) . Importantly, it was observed that Vtiss in obese participants 55 , whether or not standardized by body height, was higher than in control subjects, although within the normal limits (Fig. 5) 58, 63 . Taken as a whole, this very novel difference was not associated with changes in the total area of CT visible vessels, neither with changes in systemic and pulmonary haemodynamics or small vessel areas (3 mm 2 < area < 5 mm 2 ). Given that the pulmonary vascular blood volume remained equal, differences in Vtiss should track the changes in volume of the lung parenchymal tissue or interstitial fluid.
THE EFFECTS OF BARIATRIC SURGERY
Bariatric surgery is well tolerated, has a profound weight-reduction effect 14, 15 and reverses the obesity-induced low-grade inflammation 41, 66 while restoring the function of perivascular adipose tissue by reducing adipose inflammation and increasing local adiponectin and NO bioavailability 50 . Along with significant weight loss and reduction of systemic inflammation after bariatric surgery, all pulmonary gas exchange disturbances, including postural-induced derangements, were also considerably improved but not completely abolished, akin to the usual bariatric surgery remnants of mild obesity and systemic inflammation, since all serum inflammatory biomarkers decreased but remained still somehow abnormal. Although mechanical factors 55 ).
can undoubtedly play a role, the finding that the correlation between oxygen-induced changes in intrapulmonary shunt and in the dispersion of pulmonary blood flow post-bariatric surgery was lost (Fig. 3B ), points to a substantial improvement in pulmonary blood flow redistribution 30 . Hence, these findings could support a causal role of obesity on gas exchange and vascular tone abnormalities in the lungs. Moreover, there is a significant improvement of arterial PO 2 while breathing 100% oxygen after bariatric surgery that can be explained by the reduction of intrapulmonary shunt observed after surgery 30, 31 .
Despite this marked reduction in intrapulmonary shunt after bariatric surgery, CT densitometry data did not show any change at the CT-lung volumes, namely end-expiratory volume, non-aerated lung volume, hypo-aerated lung volume (Fig. 4) . Most likely, this can be also explained by the higher variability along with a slightly lower resolution of CT lung imaging, a topographical approach, compared to the power of the state-of-the art inert gases approach. Accordingly, if we consider, first, that the latter finding fails to include the pulmonary blood flow within the non-ventilated areas and, second, that it can be a more sensitive and less variable tool than lung imaging to detect the amounts of intrapulmonary shunt, it should be expected to observe more noticeable changes on inert gas shunt and less on imaging hypo-aerated and non-aerated lung areas. By contrast, there was a significant reduction of Vtiss in the obese participants (Fig. 5 ) without associated reductions in the post-operative vascular area (i.e. pulmonary vessels < 5 mm 2 ) after bariatric surgery 55 . Neither were correlations between changes in Vtiss and any pulmonary haemodynamic changes. Given that the pulmonary vascular blood volume remained unchanged, Vtiss variations should track the changes in volume of the lung parenchymal tissue. It is therefore conceivable that before bariatric surgery systemic (and pulmonary as well) inflammation could have increased extra-vascular lung water, thereby being in part responsible for the elevated pre-bariatric surgery Vtiss in obese subjects compared with controls and for its subsequent reduction after bariatric surgery. Accordingly, these findings are consistent with the presence of increased serum inflammatory biomarkers before bariatric surgery and their post-operative reduction. In addition, changes in Vtiss could have also been related to a potential reduction in systemic (and perhaps pulmonary) inflammation after bariatric surgery 41, 66 which would be consistent with the improvement in all pre-bariatric surgery pulmonary gas exchange disturbances 30, 31 . However, at present it is not possible to unravel which of these mechanisms was more influential.
CONCLUSIONS
Obesity-induced pulmonary gas exchange abnormalities (increased alveolar-arterial O 2 difference with or without mild hypoxaemia) in non-smoking morbidly obese candidates to bariatric surgery are linked to ventilation-perfusion imbalance, namely mild-to-moderate intrapulmonary shunt and increased dispersions of pulmonary blood flow and ventilation distributions. These abnormalities can be secondary to thoracic and abdominal compression by extra-pulmonary adipose tissue that reduces chest volume; most tellingly, during hyperoxic conditions, intrapulmonary shunt increases Eva Rivas et al.: The Lung and Obesity without reversion of hypoxic pulmonary vasoconstriction. This may well reflect a less responsive pulmonary vasculature in the context of low-grade chronic systemic inflammation. Altogether these findings are consistent with an increased Vtiss in the morbidly obese compared to lean individuals and may be related to elevated extra-vascular lung water (due to low-grade systemic inflammation). Bariatric surgery induces weight loss, reduces systemic inflammation and likely pulmonary perivascular adipose tissue, thus considerably improving lung volumes and pulmonary gas exchange defects, with Vtiss reduction. In sum, bariatric surgery is associated with an effective reversion of the obese-induced lung function and imaging disturbances in addition to reducing fat tissue in morbidly obese individuals.
